Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nanoscale Adv ; 6(12): 3229-3238, 2024 Jun 11.
Article in English | MEDLINE | ID: mdl-38868819

ABSTRACT

Due to the expansion of the aquaculture industry in the world and the importance of controlling ammonia in fish breeding water, high levels of which impose significant damage to fish farming, it is crucial to develop affordable, rapid, and on-site methods for timely and accurate detection of ammonia. In this study, a colorimetric sensor based on the formation of gold/silver core/shell nanorods (NRs) was developed for the rapid detection of ammonia. The sensor functioned by the specific dissolution of silver(i) oxide by ammonia, which triggered the activation of silver ions and the subsequent formation of gold/silver core/shell NRs in the presence of a reducing agent (i.e., ascorbic acid (AA)). This led to changes in the surface composition, size, and aspect ratio of the NRs, which was accompanied by a vivid color change from green to red/orange in less than a minute. The colorimetric sensor was optimized by adjusting the effective parameters, including ascorbic acid, silver ion, and sodium hydroxide concentration as well as pH and reaction time. After the optimization process, the sensor was found to have a linear range from 50 to 800 µmol L-1 (0.85-13.6 ppm). In addition, the application of the sensor was validated by measuring the ammonia content in water samples from rearing ponds for rainbow trout, sturgeon, and tilapia before and after feeding. The sensor's label-free, rapid, user-friendly, naked-eye, and cost-effective operation makes it an attractive option for on-site environmental monitoring of ammonia.

2.
Clin Cardiol ; 47(1): e24211, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38269632

ABSTRACT

This meta-analysis aimed to evaluate the effects of flaxseed supplementation on weight loss, lipid profiles, high-sensitivity C-reactive protein (hs-CRP), and glucose levels in patients with coronary artery disease (CAD). A systematic search was performed using various online databases, including Scopus, PubMed, Web of Science, EMBASE, and Cochrane Library, to identify relevant randomized controlled trials (RCTs) until June 2023. To evaluate heterogeneity among the selected studies, the Q-test and I2 statistics were employed. Data were combined using either a fixed- or random-effects model and presented as a weighted mean difference (WMD) with a 95% confidence interval (CI). Of the 428 citations, six RCTs were included. The pooled results did not show significant changes in the WMD of lipid factors (high-density lipoprotein cholesterol, triglycerides (TG), low-density lipoprotein cholesterol, and total cholesterol) following flaxseed intake. However, after performing a sensitivity analysis to determine the source of heterogeneity, flaxseed supplementation resulted in a significant decrease in TG levels (WMD = -18.39 mg/dL; 95% CI: -35.02, -1.75). Moreover, no significant differences were observed in either weight or BMI following flaxseed intake. However, the circulating levels of fasting blood glucose (WMD = -8.35 mg/dL; 95% CI: -15.01, -1.69, p = .01) and hs-CRP (WMD = -1.35 mg/L; 95% CI: -1.93, -0.77, p < .01) significantly decreased after the intervention. Flaxseed supplementation was associated with lowering FBS, hs-CRP, and TG levels but did not affect weight loss parameters and other lipid markers in CAD.


Subject(s)
Coronary Artery Disease , Flax , Humans , C-Reactive Protein , Glucose , Randomized Controlled Trials as Topic , Cholesterol, HDL , Weight Loss , Dietary Supplements
SELECTION OF CITATIONS
SEARCH DETAIL
...